Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Appoints Bruce Cousins as Executive Vice President and Chief Financial Officer Oct 07, 2013 Tekmira Appoints Bruce Cousins as Executive Vice President and Chief Financial Officer 18.7 KB ... Read more Summary ToggleTekmira Presents TKM-PLK1 Data at 6th Annual North American Neuroendocrine Tumor Society (NA-NETS) Conference Oct 04, 2013 Tekmira Presents TKM-PLK1 Data at 6th Annual North American Neuroendocrine Tumor Society (NA-NETS) Conference 25 KB ... Read more Summary ToggleTekmira to Host Research and Development Webinar Providing Corporate Update on Product Pipeline Oct 03, 2013 Tekmira to Host Research and Development Webinar Providing Corporate Update on Product Pipeline 13.5 KB ... Read more Summary ToggleTekmira Presents New Anti-Viral Efficacy Data Against the Marburg Hemorrhagic Fever Virus Sep 25, 2013 Tekmira Presents New Anti-Viral Efficacy Data Against the Marburg Hemorrhagic Fever Virus 25.6 KB Studies Achieved 100% Protection Against Most Deadly Strain of Marburg Virus When Dosed 24 Hours After Lethal Exposure Levels in Non-Human Primates Using RNAi Therapeutic Developed by Tekmira and Its Collaborators ... Read more Summary ToggleTekmira Provides Update on Licensed Product Candidate, Marqibo(R) Sep 03, 2013 Tekmira Provides Update on Licensed Product Candidate, Marqibo(R) 19.2 KB Spectrum Pharmaceuticals Launches Marqibo and Ships First Commercial Orders ... Read more Summary ToggleTekmira's Lipid Nanoparticle (LNP) Technology Highlighted in Two Peer-Reviewed Scientific Publications Aug 30, 2013 Tekmira's Lipid Nanoparticle (LNP) Technology Highlighted in Two Peer-Reviewed Scientific Publications 24 KB ... Read more Summary ToggleTekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer Aug 12, 2013 Tekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer 39.7 KB ... Read more Summary ToggleTekmira Provides Corporate Update and Announces Second Quarter 2013 Results Aug 12, 2013 Tekmira Provides Corporate Update and Announces Second Quarter 2013 Results 39.7 KB Conference Call at 4:30 pm Eastern Time Today ... Read more Summary ToggleTekmira Initiates TKM-PLK1 Phase I/II Clinical Trial, Enrolling Patients With Advanced Gastrointestinal Neuroendocrine Tumors (GI-NET) or Adrenocortical Carcinoma (ACC) Aug 12, 2013 Tekmira Initiates TKM-PLK1 Phase I/II Clinical Trial, Enrolling Patients With Advanced Gastrointestinal Neuroendocrine Tumors (GI-NET) or Adrenocortical Carcinoma (ACC) 39.7 KB Future Clinical Development Plans Outlined for Tekmira's Oncology Therapeutic, TKM-PLK1 ... Read more Summary ToggleTekmira to Present at 2013 Wedbush Life Sciences Conference Aug 07, 2013 Tekmira to Present at 2013 Wedbush Life Sciences Conference 11.7 KB ... Read more Pagination First page First Previous page Previous … Page 32 Current page 33 Page 34 Page 35 … Next page Next Last page Last Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Appoints Bruce Cousins as Executive Vice President and Chief Financial Officer Oct 07, 2013 Tekmira Appoints Bruce Cousins as Executive Vice President and Chief Financial Officer 18.7 KB ... Read more Summary ToggleTekmira Presents TKM-PLK1 Data at 6th Annual North American Neuroendocrine Tumor Society (NA-NETS) Conference Oct 04, 2013 Tekmira Presents TKM-PLK1 Data at 6th Annual North American Neuroendocrine Tumor Society (NA-NETS) Conference 25 KB ... Read more Summary ToggleTekmira to Host Research and Development Webinar Providing Corporate Update on Product Pipeline Oct 03, 2013 Tekmira to Host Research and Development Webinar Providing Corporate Update on Product Pipeline 13.5 KB ... Read more Summary ToggleTekmira Presents New Anti-Viral Efficacy Data Against the Marburg Hemorrhagic Fever Virus Sep 25, 2013 Tekmira Presents New Anti-Viral Efficacy Data Against the Marburg Hemorrhagic Fever Virus 25.6 KB Studies Achieved 100% Protection Against Most Deadly Strain of Marburg Virus When Dosed 24 Hours After Lethal Exposure Levels in Non-Human Primates Using RNAi Therapeutic Developed by Tekmira and Its Collaborators ... Read more Summary ToggleTekmira Provides Update on Licensed Product Candidate, Marqibo(R) Sep 03, 2013 Tekmira Provides Update on Licensed Product Candidate, Marqibo(R) 19.2 KB Spectrum Pharmaceuticals Launches Marqibo and Ships First Commercial Orders ... Read more Summary ToggleTekmira's Lipid Nanoparticle (LNP) Technology Highlighted in Two Peer-Reviewed Scientific Publications Aug 30, 2013 Tekmira's Lipid Nanoparticle (LNP) Technology Highlighted in Two Peer-Reviewed Scientific Publications 24 KB ... Read more Summary ToggleTekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer Aug 12, 2013 Tekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer 39.7 KB ... Read more Summary ToggleTekmira Provides Corporate Update and Announces Second Quarter 2013 Results Aug 12, 2013 Tekmira Provides Corporate Update and Announces Second Quarter 2013 Results 39.7 KB Conference Call at 4:30 pm Eastern Time Today ... Read more Summary ToggleTekmira Initiates TKM-PLK1 Phase I/II Clinical Trial, Enrolling Patients With Advanced Gastrointestinal Neuroendocrine Tumors (GI-NET) or Adrenocortical Carcinoma (ACC) Aug 12, 2013 Tekmira Initiates TKM-PLK1 Phase I/II Clinical Trial, Enrolling Patients With Advanced Gastrointestinal Neuroendocrine Tumors (GI-NET) or Adrenocortical Carcinoma (ACC) 39.7 KB Future Clinical Development Plans Outlined for Tekmira's Oncology Therapeutic, TKM-PLK1 ... Read more Summary ToggleTekmira to Present at 2013 Wedbush Life Sciences Conference Aug 07, 2013 Tekmira to Present at 2013 Wedbush Life Sciences Conference 11.7 KB ... Read more Pagination First page First Previous page Previous … Page 32 Current page 33 Page 34 Page 35 … Next page Next Last page Last
Tekmira Presents TKM-PLK1 Data at 6th Annual North American Neuroendocrine Tumor Society (NA-NETS) Conference 25 KB
Tekmira to Host Research and Development Webinar Providing Corporate Update on Product Pipeline 13.5 KB
Tekmira's Lipid Nanoparticle (LNP) Technology Highlighted in Two Peer-Reviewed Scientific Publications 24 KB
Tekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer 39.7 KB
Tekmira Initiates TKM-PLK1 Phase I/II Clinical Trial, Enrolling Patients With Advanced Gastrointestinal Neuroendocrine Tumors (GI-NET) or Adrenocortical Carcinoma (ACC) 39.7 KB